$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
What are the adverse reactions of tipotinib hydrochloride and how to deal with them?
2025-10-19 11:44:20
Check Details
What are the side effects of Osimertinib? Will the side effects of Osimertinib always occur?
2025-10-19 11:44:20
Check Details
What are the side effects of cabozantinib and how to reduce the side effects?
2025-10-19 11:44:20
Check Details
Can cabozantinib be stopped if side effects occur? What are the precautions?
2025-10-19 11:44:20
Check Details
What are the common adverse reactions of nivolumab and what should we pay attention to?
2025-10-19 11:44:20
Check Details
What are the side effects of gefitinib and what are the contraindications?
2025-10-19 11:44:20
Check Details
How to deal with severe rashes after taking gefitinib, and how long does it take for the side effects to disappear?
2025-10-19 11:44:20
Check Details
What are the side effects of erlotinib and how to deal with them?
2025-10-19 11:44:20
Check Details
What are the side effects of afatinib, and will they last forever?
2025-10-19 11:44:20
Check Details
What are the side effects of Osimertinib and how long does it take for them to appear? _ Kanghule
2025-10-19 11:44:20
Check Details
What are the side effects of dacomitinib? How to adjust the medication if the side effects are too great?
2025-10-19 11:44:20
Check Details
What are the side effects of crizotinib and how long will they last?
2025-10-19 11:44:20
Check Details
1
2
...
10150
10151
10152
10153
10154
10155
10156
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma